AI assistant
INSMED Inc — Director's Dealing 2021
Mar 11, 2021
30150_dirs_2021-03-11_4189b39f-bac7-45c2-a55c-0ab061738bb4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2021-03-09
Reporting Person: SORIANO JOHN (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-03-09 | Common Stock | M | 13433 | $30.86 | Acquired | 43206 | Direct |
| 2021-03-09 | Common Stock | S | 13433 | $40.38 | Disposed | 29773 | Direct |
| 2021-03-09 | Common Stock | M | 17349 | $13.91 | Acquired | 47122 | Direct |
| 2021-03-09 | Common Stock | S | 17349 | $40.38 | Disposed | 29773 | Direct |
| 2021-03-09 | Common Stock | M | 14130 | $23.75 | Acquired | 43903 | Direct |
| 2021-03-09 | Common Stock | S | 14130 | $40.38 | Disposed | 29773 | Direct |
| 2021-03-10 | Common Stock | M | 500 | $30.86 | Acquired | 30273 | Direct |
| 2021-03-10 | Common Stock | S | 500 | $40 | Disposed | 29773 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-03-09 | Stock Option (right to buy) | $30.86 | M | 13433 | Disposed | 2028-01-22 | Common Stock (13433) | Direct |
| 2021-03-09 | Stock Option (right to buy) | $13.91 | M | 17349 | Disposed | 2029-01-03 | Common Stock (17349) | Direct |
| 2021-03-09 | Stock Option (right to buy) | $23.75 | M | 14130 | Disposed | 2030-01-03 | Common Stock (14130) | Direct |
| 2021-03-10 | Stock Option (right to buy) | $30.86 | M | 500 | Disposed | 2028-01-22 | Common Stock (500) | Direct |
Footnotes
F1: This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.61 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F2: This is the weighted average sales price representing the shares sold at prices ranging from $40.00 to $40.01 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
F3: The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.